Prevalence of HIV-1 resistant strains in recent seroconverters

Journal of Biological Regulators and Homeostatic Agents

Volumn 14, Issue 1, 2000, Pages 51-57

  Balotta, C ^a   Berlusconi, A ^a   Pan, A ^a   Violin, M ^a   Riva, C ^a   Gori, A ^a   Carvasce, S ^a   Mazzucchelli, R ^a   Facchi, G ^a   Velleca, R ^a   Senese, D ^a   Deho, L ^a   Galli, M ^a   Rusconi, S ^a   Moroni, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute HIV 1 infection; Genotype; Phenotype; Protease; Resistance; Reverse transcriptase

Indexed keywords

INDINAVIR; POL PROTEIN; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVALENCE; PRIMARY INFECTION; RETROSPECTIVE STUDY; SEROCONVERSION; VIREMIA; VIRUS ISOLATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034456739     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mutations in retroviral genes associated with drug resistance: 1999-2000 update
2. Brief report: Primary infection with zidovudine-resistant human immunodeficiency virus type 1
3. Transmission of zidovudine-resistant HIV-1
4. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance
5. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year
6. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1
7. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation
8. Public health implications of antiretroviral therpay and HIV drug resistance
9. Mutation associated with zidovudine resistance in HIV-1 among recent seroconvertors
10. Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996
11. Prevalence of genotypic resistance to nucleoside analogues in anti-retroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
12. Pol gene quasispecies of human immunodeficiency virus: Mutations associated with drug resistance in virus from patients undergoing no drug therapy
13. Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors
14. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
15. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multi-center quality assurance program for the AIDS clinical trials group
16. HIV type 1 phenotype correlates with the stage of infection in vertically infected children
17. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection
18. Endpoint methods - Measurements of the infectious titer of a viral sample
19. Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial
20. Human retroviruses and AIDS: A compilation and analysis of nucleic acid and amino acid sequences
21. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
22. Reversion of lamivudine resistance in a zidovudine and lamivudine dual-resistant human immunodeficiency virus type 1 (HIV-1) isolate after discontinuation of in vitro lamivudine drug pressure
23. Baseline resistance profile predicts response to ritonavir/ saquinavir therapy in a community setting
24. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays
25. Antiretroviral drug resistance testing in adults with HIV infection. Implication for clinical management
26. Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity